Clinical Trial Update: Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Reolysin with docetaxel and prednisone versus docetaxel and prednisone alone in metastatic castration-resistant prostate cancer has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• PREDNISONE (Prednisone)
• REOLYSIN (pelareorep)

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED